GlassScriptPhysician profile
Scott E Hastings
NPI 1174597553
$1,117.18
in general payments reported to CMS, 2019-2025
36 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.60 · 2020: $53.32 · 2021: $74.54 · 2022: $153 · 2023: $370 · 2024: $291 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $159.17 | 2022-2025 | |
| Si-Bone, INC. | $60.55 | 2022-2025 | |
| Lilly USA, LLC | $53.46 | 2020-2024 | Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.26 | 2023-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $51.15 | 2023-2024 | Rexulti |
| Medtronic, INC. | $44.11 | 2021-2025 | Venaseal |
| Abbvie INC. | $41.45 | 2023-2024 | |
| Inspire Medical Systems, INC. | $41.10 | 2024 | Inspire |
| Idorsia Pharmaceuticals US INC | $39.19 | 2023 | Quviviq |
| Exact Sciences Corporation | $35.17 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $32.93 | 2019-2022 | |
| Abbott Laboratories | $30.88 | 2021-2023 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $30.74 | 2021-2023 | Qelbree |
| Ironshore Pharmaceuticals INC. | $27.06 | 2023 | Jornay Pm |
| Biohaven Pharmaceutical Holding Company LTD. | $26.93 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25.52 | 2024 | Repatha, Otezla |
| Photonicare INC | $25.06 | 2025 | Otosight Middle Ear Scope |
| Alk-Abello, INC | $21.86 | 2023 | Grastek, Ragwitek, Odactra |
| Ultragenyx Pharmaceutical INC. | $21.47 | 2022 | |
| Horizon Therapeutics Plc | $20.94 | 2023 | Krystexxa |
| Linus Health, INC. | $20.73 | 2023 | |
| Tempus Ai, INC | $19.45 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $19.38 | 2021 | |
| Sanofi Pasteur INC. | $19.20 | 2023 | |
| Merck Sharp & Dohme LLC | $19.17 | 2023 | Gardasil 9, Vaqta, Vaxneuvance |
| Sunovion Pharmaceuticals INC. | $18.93 | 2022 | |
| Antares Pharma, INC. | $18.56 | 2024 | Xyosted |
| Genentech USA, INC. | $17.86 | 2022 | |
| Nevro Corp. | $16.67 | 2023 | Senza |
| Astellas Pharma US INC | $16.43 | 2025 | Veozah |
| Acella Pharmaceuticals, LLC | $16.24 | 2024 | NP Thyroid 60 |
| Endo Pharmaceuticals INC. | $16.21 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.08 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $14.78 | 2023 | Shingrix, Arexvy |
| Viiv Healthcare Company | $13.63 | 2024 | Apretude |
| Jazz Pharmaceuticals INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hastings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.